A 72-week double-blind, placebo-controlled, delayed-start trial of rasagiline 1 mg or 2 mg in PD reported a reduction in motor progression as measured by the UPDRS score in the 1 mg group versus placebo, but the 2 mg group did not meet any prespecified endpoints [202]
Adults over 50 are more likely to develop B12 deficiency without realizing it, especially if symptoms like fatigue, memory loss, or mood changes are attributed to aging itself
Since clinical trials and research for retatrutide are still in progress, there is no official or finalized dosing schedule yet
10.1172/jci.insight.140532 62 XiaoQ.JengW.WheelerM
Metformin's contribution to weight stability, insulin sensitivity improvement, and background GLP-1 enhancement creates a metabolic environment where tirzepatide can work more effectively
Most recently, we added VRB-101 for Obesity, VRB-101 for Obesity and Ponsegromab for Pancreatic Cancer to the Power online platform.